Translational Control: Selective Upregulation of ECM Components Drives Tumour Growth
A new mechanistic link has been identified between the expression of initiator methionine tRNA and cancer progression, whereby elevated levels of this tRNA specifically drive synthesis of secretome components, resulting in a type II collagen-rich matrix that promotes tumour progression. A new mechan...
Saved in:
Published in | Current biology Vol. 26; no. 6; pp. R241 - R243 |
---|---|
Main Author | |
Format | Journal Article |
Language | English |
Published |
England
Elsevier Ltd
21.03.2016
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | A new mechanistic link has been identified between the expression of initiator methionine tRNA and cancer progression, whereby elevated levels of this tRNA specifically drive synthesis of secretome components, resulting in a type II collagen-rich matrix that promotes tumour progression.
A new mechanistic link has been identified between the expression of initiator methionine tRNA and cancer progression, whereby elevated levels of this tRNA specifically drive synthesis of secretome components, resulting in a type II collagen-rich matrix that promotes tumour progression. |
---|---|
ISSN: | 0960-9822 1879-0445 |
DOI: | 10.1016/j.cub.2016.01.053 |